netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Niraparib found 4 matches

Open monograph to display formulary status BNF Category
  Niraparib  (Zejula®) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (Oct 2020): Niraparib (Zejula▼): reports of severe hypertension and posterior reversible encephalopathy syndrome (PRES), particularly in early treatment (08.01.05)
link in drug section NICE TA673: Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy (08.01.05)
link in drug section NICE TA784: Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer (08.01.05)


 

netFormulary